Eledon Pharmaceuticals, Inc. (ELDN) 8-K Current Report — March 19, 2026
Filed: March 19, 2026
Health Care
Pharmaceutical PreparationsEledon Pharmaceuticals, Inc. (ELDN) 8-K current report filed with SEC EDGAR on March 19, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
Eledon Pharmaceuticals, Inc. 8-K Mar 19, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Reporting of financial results for quarter and year ended December 31, 2025
- • Results announced via press release dated March 19, 2026, attached as Exhibit 99.1
Get deeper insights on Eledon Pharmaceuticals, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.